“Induction of an inflammatory tumour micro-environment” That statement in the title already tells us that CF33 is turning cold tumours “hot” - ie visible to the immune system and open to immune system attack.
I think that justifies the “Price Sensitive” tag.
The downrampers will want more than that - and do do I - but we will find out when the conference comes around, starting with release on Abstracts.
Cheers
Dave
Ann: Imugene HER-Vaxx and CHECKVacc to be Featured at ESMO, page-18
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $382.1K | 7.853M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 8072405 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 668099 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |